RecruitingPhase 3NCT06959095
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
Sponsor: GlaxoSmithKline
Corsicana, TX · Dallas, TX · Houston, TX · +39 more sites